Vertex Pharmaceuticals Inc. sell Robert W. Baird
Start price
31.01.24
/
50%
€400.05
Target price
31.01.25
€299.00
Performance (%)
10.29%
End price
01.02.25
€441.20
Summary
This prediction ended on 01.02.25 with a price of €441.20. The prediction closed with a disappointing performance of 10.29%. Robert_W__Baird has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Sell. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 5.246% | 5.246% | 16.652% |
| iShares Core DAX® | 4.367% | 4.830% | 8.167% |
| iShares Nasdaq 100 | -0.294% | 3.311% | 34.822% |
| iShares Nikkei 225® | -0.471% | 8.527% | 62.385% |
| iShares S&P 500 | 1.267% | 2.858% | 25.640% |
Comments by Robert_W__Baird for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Robert_W__Baird gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was downgraded by analysts at Robert W. Baird from a "neutral" rating to an "underperform" rating. They now have a $325.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by Robert_W__Baird for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€464.00
07.07.26
07.07.26
€306.01
07.07.27
07.07.27
-1.41%
07.07.26
07.07.26
